Overview
Leaphy provides a unified platform serving patients, healthcare providers, pharmacists, and pharmaceutical companies to manage electronic Product Information (ePI) leaflets across EU markets. The service includes a free patient app for barcode scanning, prescriber tools with drug classification and pricing data, pharmacy search functionality, and an API-driven platform for pharma companies to publish compliant leaflets.
Key people
In the news
- Something big is changing in European medicine information. And we think more people should be talking about it. Electronic Product Information — ePI — is moving closer to real-world implementation. EMA has published its draft implementation roadmap. National competent authorities are preparing. Industry is running pilots across Europe. In fact, a recent overview from AESGP, EFPIA - European Federation of Pharmaceutical Industries and Associations and Medicines for Europe identified ePI pilot activity across 31 European
- Why now for ePI? Three things are lining up at once: Europe's move from paper leaflets to structured electronic product information is accelerating, the standards to do it properly (HL7 FHIR, ISO IDMP) are maturing, and pharma needs to manage leaflet data across every EU market. Leaphy sits exactly at that intersection — already live in Belgium, built on the standards, and expanding market by market. A standards-based platform for a market in its earliest stage. If you're building or backing the future of medicines information,
- Built on standards" isn't a slogan for us — it's the architecture. Leaphy is built on the EU Common Standard for ePI and the EMA's HL7 FHIR Implementation Guide, with metadata aligned to ISO IDMP and the Falsified Medicines Directive. That's what makes structured leaflet data portable, compliant, and ready for the systems pharma and healthcare already run. Standards are how digital health scales. We're all in. #FHIR #IDMP #ePI #interoperability #healthtech
- Managing leaflets across 27 markets shouldn't mean 27 processes. With Leaphy, you transform your leaflets into structured ePI once, then manage and publish across all EU markets from a single platform — metadata aligned with FMD and ISO IDMP, secured in Azure, delivered via app and API, with push updates to patients and prescribers. One source of leaflet truth. Every market, every language. Want to see it on your portfolio? Let's talk → leaphy.com/contact #regulatoryaffairs #IDMP #pharma #digitaltransformation
- Accelerate your transition to EMA-ready ePI. Move from legacy leaflets to EMA-ready ePI. Leaphy helps pharmaceutical organisations convert Word and PDF product information into structured, FHIR-compliant electronic Product Information with AI-supported conversion workflows, built-in quality control, and a path toward scalable ePI operations. Explore this service on the enw website: www.leaphy.com
- The paper package leaflet is on its way out. Europe is moving to electronic product information (ePI) on a common standard built on HL7 FHIR — structured, multilingual, machine-readable. For pharma, that's a new operating model for how medicines information reaches patients and prescribers across every EU market. Leaphy was built for exactly this transition. What's your team's biggest open question on ePI? 👇 #ePI #regulatoryaffairs #FHIR #pharma
- Pleased to share that Leaphy has been nominated for Healthtech Company of the Year (Global) at the Koncept Conference. We don't build for awards — we build to make medication information clear, trusted and accessible. Scan a pack, get a structured leaflet in your own language; the same source of truth serving patients, physicians, pharmacists and pharma across Europe. This nomination is a welcome nod to the team and partners helping bring Europe's medicines leaflets into the ePI era. Thank you, and onward. #HealthTech #ePI
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.